"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!


(la-BET-uh-lahl HIGH-droe-KLOR-ide)
Normodyne, Trandate
Class: Alpha-adrenergic blocker/beta-adrenergic blocker

 Action Selectively blocks alpha-1 receptors and nonselectively blocks beta-receptors to decrease BP, heart rate and myocardial oxygen demand.

 Indications Management of hypertension. Unlabeled use(s): Treatment of pheochromocytoma; management of clonidine-withdrawal hypertension.

 Contraindications Severe bradycardia; second- and third-degree heart block; heart failure; cardiogenic shock; bronchial asthma.

 Route/Dosage

ADULTS: PO 100 mg bid initially; maintenance dose usually 200 to 400 mg bid. IV 20 mg over 2 min; then 40 to 80 mg q 10 min up to maximum of 300 mg. Infusions of 2 mg/min can be initiated and titrated to response.

 Interactions

Beta-adrenergic agonists: Blunted bronchodilator effect. Cimetidine: Increased bioavailability of labetalol. Indomethacin: Impaired antihypertensive effect of labetalol. Inhalation anesthetics: May exaggerate hypotension. Nitroglycerin: Increased hypotension. INCOMPATABILITIES: Injection not compatible with 5% sodium bicarbonate.

 Lab Test Interferences Drug may cause false-positive increases in levels of urinary catecholamines.

 Adverse Reactions

CV: Orthostatic hypotension; edema; flushing; ventricular arrhythmias; atrioventricular block; bradycardia; heart failure; chest pain. CNS: Headache; fatigue; dizziness; depression; lethargy; drowsiness; forgetfulness; sleepiness; vertigo; paresthesias; nightmares. DERM: Tingling of scalp; rash; facial erythema; alopecia; urticaria; pruritus; increased sweating. EENT: Dry eyes; visual disturbances; altered taste perception. GI: Nausea; vomiting; diarrhea; dyspepsia. GU: Impotence; urinary retention; difficulty with urination; failure to ejaculate; priapism; Peyronie’s disease. HEMA: Leukopenia. HEPA: Elevated transaminases; jaundice; cholestasis. META: Increases or decreases in serum glucose; increased creatinine and BUN. RESP: Bronchospasm; shortness of breath; wheezing. OTHER: Muscle cramps; systemic lupus erythematosus; increased hypoglycemic response to insulin; masking of hypoglycemic signs; asthenia.

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established. Special risk patients: Use drug with caution in patients with diabetes mellitus, CHF, respiratory difficulties or severely elevated BP. Cardiac failure: Has been observed in patients with or without history of cardiac failure. Withdrawal: Do not discontinue abruptly. Abrupt discontinuation may worsen angina and precipitate ischemic event in susceptible individuals.


PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • Administer oral form with food. Tablets can be crushed.
  • If nausea and dizziness occur with twice daily dosing of oral form, same total daily dose can be administered as divided doses 3 times/day.
  • Keep patient supine during IV administration and for 3 hr afterward.
  • For repeated IV injection, give 20 mg dose slowly over 2 min.
  • For slow continuous infusion, dilute contents with compatible IV fluid and administer at rate of 2 mg/min. Use controlled administration device. Once satisfactory response is obtained, infusion can be discontinued and treatment with oral labetalol can be initiated.
  • Labetalol is compatible with following parenteral solutions: Ringer’s, lactated Ringer’s 5% Dextrose and Ringer’s, 5% lactated Ringer’s and 5% Dextrose, 5% Dextrose, 0.9% Sodium Chloride, 5% Dextrose and 0.2% Sodium Chloride, 2.5% Dextrose and 0.45% Sodium Chloride, 5% Dextrose and 0.9% Sodium Chloride and 5% Dextrose and 0.33% Sodium Chloride.
  • Store at room temperature and protect from excessive moisture.
  • Do not freeze injection vials. Protect from light. Parenteral solution is stable for 24 hr after dilution.

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Measure vital signs and supine BP immediately before and at 5 to 10 min intervals after direct IV injection.
  • Obtain renal and liver studies before therapy begins.
  • Take safety precautions if orthostatic hypotension occurs.
  • Closely monitor diabetic patients for signs of hypoglycemia.
  • Assess skin turgor and dryness of mucous membranes for hydration status.
OVERDOSAGE: SIGNS & SYMPTOMS
  Excessive orthostatic hypotension, excessive bradycardia, cardiac failure, bronchospasm, seizures

 Patient/Family Education

  • Caution patient to avoid sudden position changes to prevent orthostatic hypotension. Advise use of support hose.
  • Advise patient to notify dentist and other physicians of drug therapy before treatment or surgery.
  • Caution diabetic patient to monitor serum glucose carefully.
  • Instruct pa4ient nod to discontinue drug abruptly.
  • Advise patient to carry identification (eg, Medi-Alert) indicating medical condition and drug regimen.
  • Instruct patient how to measure BP and pulse.
  • Emphasize importance of other modalities on BP: Weight control, regular exercise, smoking cessation and moderate intake of alcohol and salt.
  • Inform patient that transient scalp tingling may occur, especially when treatment is initiated.
  • Instruct patient to report the following symptoms to physician: Slow heart rate, dizziness, confusion, fever or depression, shortness of breath, fatigue, swelling of ankles and feet.
  • Advise patient that drug causes dizziness and to use caution while driving or performing other tasks requiring mental alertness.
  • Instruct patient not to take any otc medications without consulting physician.

Popularity: 2% [?]


If you're still unable to find appropriate information in the article, please use search form below